DAWN Financials
Day One Biopharmaceuticals Inc - Financial statements & key metrics
Stock Price
$12.11
Market Cap
$1.24B
EPS
$-1.52
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$131.16M
Gross Profit
-
Operating Income
-
Net Income
$-95.50M
EPS (Diluted)
$-1.02
Balance Sheet Highlights
Total Assets
$582.79M
Total Liabilities
$80.04M
Shareholders Equity
-
Cash & Equivalents
$124.97M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-78.11M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
89.4%
Operating Margin
-0.6%
Net Margin
-1.1%
ROE
-0.3%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is DAWN revenue?
DAWN's most recent quarterly revenue was $131.16M. Annual revenue can be calculated by summing the four most recent quarters.
Is DAWN profitable?
DAWN reported a loss of $95.50M in the most recent quarter. The net profit margin is -1.1%.
What is DAWN market cap?
DAWN has a market capitalization of $1.24B, making it a small-cap stock.
Does DAWN have debt?
View DAWN's balance sheet for debt information.
What is DAWN cash flow?
Cash flow data is available in the full financial statements.